Clinical Trials
All Clinical Trials - Page 10 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06884293Phase 3Active Not Recruiting
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）
Semaglutide
- NCT06807437Phase 3Recruiting
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Lanreotide
- NCT07029009Phase 2Recruiting
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Liraglutide
- NCT06965413Phase 2Active Not Recruiting
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
Tirzepatide
- NCT06939088Phase 2Recruiting
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Tirzepatide
- NCT06901245Phase 4Recruiting
Tirzepatide in PWS, HO and GNSO
Tirzepatide
- NCT07057310Phase 4Enrolling By Invitation
Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
Tirzepatide
- NCT07055607N/AEnrolling By Invitation
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
Semaglutide
- NCT06865365Phase 4Not Yet Recruiting
Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
Liraglutide
- NCT06951776N/ANot Yet Recruiting
Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis
Teriparatide
- NCT07460908N/ACompleted
Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome
Octreotide
- NCT07109700Phase 2Recruiting
A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
Dulaglutide
- NCT06952530Phase 3Active Not Recruiting
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Orforglipron
- NCT06948435Phase 3Active Not Recruiting
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
Orforglipron
- NCT06948422Phase 3Active Not Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Orforglipron
- NCT06914895Phase 3Active Not Recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Tirzepatide
- NCT06926842Phase 2Active Not Recruiting
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
Petrelintide
- NCT06972992Phase 1Completed
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide
Semaglutide
- NCT07429032Phase 1Completed
The Effect of AMG 133 on Gastric Emptying
Maridebart-Cafraglutide
- NCT06528210Phase 2Withdrawn
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
Gonadorelin
- NCT07076030Phase 1Completed
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Petrelintide
- NCT06706284Phase 4Recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Semaglutide
- NCT06916065Phase 1Completed
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Tirzepatide
- NCT06802081Phase 2Recruiting
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Tirzepatide
- NCT06911203Phase 2Recruiting
A Study of BGM0504 in Participants With Obesity
Tirzepatide
- NCT06619015Phase 2/Phase 3Withdrawn
Tailoring Obesity Treatment Trial
Semaglutide
- NCT06966687N/AEnrolling By Invitation
Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
Thymosin-Alpha-1
- NCT06862908Phase 2Recruiting
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
Mazdutide
- NCT06951854Phase 2Recruiting
Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder
Petrelintide
- NCT06894784Phase 3Recruiting
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
Semaglutide
- NCT07244003Phase 4Recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Liraglutide
- NCT06897475Phase 2Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Tirzepatide
- NCT06721507Phase 4Recruiting
2024 Tirzepatide-Bariatric Surgery
Tirzepatide
- NCT06745284Phase 1Active Not Recruiting
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
Semaglutide
- NCT06890611Phase 1Completed
A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
Tirzepatide
- NCT06937060Phase 3Recruiting
Effect of Semaglutide in Patients With Psoriasis and Obesity
Semaglutide
- NCT06857942Phase 4Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Tirzepatide
- NCT06893211Phase 2Completed
Effect of Tirzepatide on Brown Adipose Tissue in Obesity
Tirzepatide
- NCT06348134Phase 2Recruiting
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Ghrp-6
- NCT07104487Phase 2Recruiting
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
Octreotide
- NCT06858878Phase 3Active Not Recruiting
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Maridebart-Cafraglutide
- NCT06856291N/ARecruiting
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
Semaglutide
- NCT07428525Phase 1Completed
A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function
Maridebart-Cafraglutide
- NCT05829460Phase 2Withdrawn
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
Semaglutide
- NCT06858839Phase 3Active Not Recruiting
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Maridebart-Cafraglutide
- NCT07429045Phase 1Completed
A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body
Maridebart-Cafraglutide
- NCT06883851N/ARecruiting
Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06734273EARLY_Phase 1Recruiting
Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
Tirzepatide
- NCT06326190Phase 2Recruiting
177Lu-DOTATATE for Recurrent Meningioma
Octreotide
- NCT06864026Phase 4Recruiting
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Tirzepatide